Exploring the Natural Pharmacopeia and Incubating a Biotech Company

As published in Pharma's Almanac

Using high-throughput screening, computer modeling based on proprietary algorithms, and disease-specific cell and animal models, GB Sciences has rationally designed plant-inspired, optimized therapeutic mixtures containing synthetic homologues that are identical copies of plant-based substances. The company has several candidates soon to enter the clinic and is taking steps to ensure their success and further advance its proprietary discovery capabilities.

Read the full article here.